Does acute hyperglycemia add prognostic value to the GRACE score in individuals with non-ST elevation acute coronary syndromes?

Clinica Chimica Acta

Volumn 410, Issue 1-2, 2009, Pages 74-78

  Correia, Luis C L ^a,b   Rocha, Mário S ^a,b   Bittencourt, Ana P ^a,b   Freitas, Rafael ^a,b   Souza, Alexandre C ^a,b   Almeida, Maria C ^a,b   Pericles Esteves J ^a,b  

^a Portuguese Hospital   (Brazil)

^b Medical School of Bahia   (Brazil)

Author keywords

Acute coronary syndromes; Glucose; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN T;

ACCURACY; ACUTE CORONARY SYNDROME; AGE; AGED; ANGINA PECTORIS; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; FEMALE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

ANGINA;

EID: 70350567784     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.09.026     Document Type: Article

References (31)

1. Deedwania P., Kosiborod M., Barrett E., et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117 (2008) 1610-1619
2. Vetter N.J., Strange R.C., Adams W., and Oliver M.F. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1 (1974) 284-288
3. Kawano H., Motoyama T., Hirashima O., et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34 (1999) 146-154
4. Aljada A., Friedman J., Ghanim H., et al. Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 55 (2006) 1177-1185
5. Ceriello A., Giacomello R., Stel G., et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 44 (1995) 924-928
6. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., and Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85 (2000) 2970-2973
7. O'Donoghue M., and Morrow D.A. The future of biomarkers in the management of patients with acute coronary syndromes. Curr Opin Cardiol 23 (2008) 309-314
8. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., and Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology Consensus Recommendations. Clin Chem 49 (2003) 1331-1336
9. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163 (2003) 2345-2353
10. Beach E.F., and Turner J.J. An enzymatic method for glucose determination in body fluids. Clin Chem 4 (1958) 462-475
11. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
12. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172
13. Peduzzi P., Concato J., Kemper E., Holford T.R., and Feinstein A.R. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49 (1996) 1373-1379
14. Yan A.T., Yan R.T., Tan M., et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J 28 (2007) 1072-1078
15. Yan R.T., Yan A.T., Granger C.B., et al. Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. Am J Cardiol 101 (2008) 919-924
16. Lim K.D., Yan A.T., Casanova A., et al. Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 155 (2008) 718-724
17. Aronson D., Hammerman H., Kapeliovich M.R., et al. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function. Diabetes Care 30 (2007) 960-966
18. Wang T.J. New cardiovascular risk factors exist, but are they clinically useful?. Eur Heart J 29 (2008) 441-444
19. Wang T.J., Gona P., Larson M.G., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355 (2006) 2631-2639
20. Svensson A.M., McGuire D.K., Abrahamsson P., and Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26 (2005) 1255-1261
21. Kadri Z., Danchin N., Vaur L., et al. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart 92 (2006) 910-915
22. Bolk J., van der P.T., Cornel J.H., Arnold A.E., Sepers J., and Umans V.A. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79 (2001) 207-214
23. Wahab N.N., Cowden E.A., Pearce N.J., et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
24. Foo K., Cooper J., Deaner A., et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
25. O'Sullivan J.J., Conroy R.M., Robinson K., Hickey N., and Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 14 (1991) 758-760
26. Bellodi G., Manicardi V., Malavasi V., et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 64 (1989) 885-888
27. Sinnaeve P.R., Steg P.G., Fox K.A., et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 169 (2009) 402-409
28. Kosiborod M., Rathore S.S., Inzucchi S.E., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
29. Stranders I., Diamant M., van Gelder R.E., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
30. Suleiman M., Hammerman H., Boulos M., et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111 (2005) 754-760
31. de Araujo G.P., Ferreira J., Aguiar C., and Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 26 (2005) 865-872